Sun Pharma misses Q1 estimates as US generics drag offsets India growth
Revenue and profit rose in double digits in the June quarter, but softer US generics sales and margin pressure saw India's largest drugmaker missing Street expectations.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Wow
0
Sad
0
Angry
0
Comments (0)